Author

Douglas Grant Osborne

University of Colorado AnschutzORCID 0000-0002-6772-7031Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Organism:mouse· 1

Frequent Co-Authors

Alexander T. NguyeniD· 1 shared Anthony J. SaviolaiD· 1 shared Benjamin Van CourtiD· 1 shared Brooke NeupertiD· 1 shared Diemmy NguyeniD· 1 shared Elena B. PasqualeiD· 1 shared Jacob GadwaiD· 1 shared Jordan JacobelliiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alexander T. NguyenORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Manipulating the EphB4-ephrinB2 axis to reduce metastasis in HSNCC

Khalid N.M. Abdelazeem, Diemmy Nguyen, Sophia Corbo, Laurel B. Darragh, Mike W. Matsumoto, Benjamin Van Court, Brooke Neupert, Justin D. Yu, Nicholas A. Olimpo, Douglas Grant Osborne, Jacob Gadwa, Richard B. Ross, Alexander T. Nguyen, Shilpa Bhatia, Mohit Kapoor, , Sana D. Karam

This study shows that targeting the EphB4-ephrinB2 axis with engineered ligands reduces metastasis in HNSCC by modulating tumor microenvironment and immune responses.

Oncogene · Nov 3, 2024Peer-reviewedCancer Biology